TP53 and head and neck squamous cell carcinoma: The adaptive response to chemotherapy in HNSCC is modulated by changes in the expression of pro- or anti-apoptotic proteins and include defects in cellular responses caused by mutations of tumor suppressor gene TP53 (30, 31).